The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study
Open accessAbstract
Objectives: To derive and validate risk prediction algorithms to estimate the risk of covid-19 related mortality and hospital admission in UK adults after one or two doses of covid-19 vaccination. Design: Prospective, population based cohort study using the QResearch database linked to data on covid-19 vaccination, SARS-CoV-2 results, hospital admissions, systemic anticancer treatment, radiotherapy, and the national death and cancer registries. Settings: Adults aged 19-100 years with one or two doses of covid-19 vaccination between 8 December 2020 and 15 June 2021. Main outcome measures: Primary outcome was covid-19 related death. Secondary outcome was covid-19 related hospital admission. Outcomes were assessed from 14 days after each vaccination dose. Models were fitted in the derivation cohort to derive risk equations using a range of predictor variables. Performance was evaluated in a separate validation cohort of general practices. Results: Of 6 952 440 vaccinated patients in the derivation cohort, 5 150 310 (74.1%) had two vaccine doses. Of 2031 covid-19 deaths and 1929 covid-19 hospital admissions, 81 deaths (4.0%) and 71 admissions (3.7%) occurred 14 days or more after the second vaccine dose. The risk algorithms included age, sex, ethnic origin, deprivation, body mass index, a range of comorbidities, and SARS-CoV-2 infection rate. Incidence of covid-19 mortality increased with age and deprivation, male sex, and Indian and Pakistani ethnic origin. Cause specific hazard ratios were highest for patients with Down’s syndrome (12.7-fold increase), kidney transplantation (8.1-fold), sickle cell disease (7.7-fold), care home residency (4.1-fold), chemotherapy (4.3-fold), HIV/AIDS (3.3-fold), liver cirrhosis (3.0-fold), neurological conditions (2.6-fold), recent bone marrow transplantation or a solid organ transplantation ever (2.5-fold), dementia (2.2-fold), and Parkinson’s disease (2.2-fold). Other conditions with increased risk (ranging from 1.2-fold to 2.0-fold increases) included chronic kidney disease, blood cancer, epilepsy, chronic obstructive pulmonary disease, coronary heart disease, stroke, atrial fibrillation, heart failure, thromboembolism, peripheral vascular disease, and type 2 diabetes. A similar pattern of associations was seen for covid-19 related hospital admissions. No evidence indicated that associations differed after the second dose, although absolute risks were reduced. The risk algorithm explained 74.1% (95% confidence interval 71.1% to 77.0%) of the variation in time to covid-19 death in the validation cohort. Discrimination was high, with a D statistic of 3.46 (95% confidence interval 3.19 to 3.73) and C statistic of 92.5. Performance was similar after each vaccine dose. In the top 5% of patients with the highest predicted covid-19 mortality risk, sensitivity for identifying covid-19 deaths within 70 days was 78.7%. Conclusion: This population based risk algorithm performed well showing high levels of discrimination for identifying those patients at highest risk of covid-19 related death and hospital admission after vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119
Statistical Analysis with Missing Data
Little, R. J. A., & Rubin, D. B. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781119013563 · Cited by 8,473
Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32661-1 · Cited by 4,616
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.639 · Cited by 3,293
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · Annals of Internal Medicine · doi:10.7326/m14-0697 · Cited by 3,267
The Statistical Analysis of Failure Time Data
Kalbfleisch, J. D., & Prentice, R. L. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781118032985 · Cited by 3,219
The Statistical Analysis of Failure Time Data
Klein, J. P. (1982) · Technometrics · doi:10.1080/00401706.1982.10487769 · Cited by 2,215
Hippisley-Cox, J., Coupland, C., & Brindle, P. (2017) · BMJ · doi:10.1136/bmj.j2099 · Cited by 1,703
Self-citationFactors That Influence the Immune Response to Vaccination
Zimmermann, P., & Curtis, N. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00084-18 · Cited by 939
Obesity Is a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms
Sattar, N., McInnes, I. B., & McMurray, J. J. V. (2020) · Circulation · doi:10.1161/circulationaha.120.047659 · Cited by 704
Landmark Analysis at the 25-Year Landmark Point
Dafni, U. (2011) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.957951 · Cited by 569
Hippisley-Cox, J., & Coupland, C. (2005) · BMJ · doi:10.1136/bmj.330.7504.1366 · Cited by 561
Self-citationGao, M., Piernas, C., Astbury, N. M., Hippisley-Cox, J., O'Rahilly, S., Aveyard, P., & Jebb, S. A. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00089-9 · Cited by 545
Self-citationClift, A. K., Coupland, C. A. C., Keogh, R. H., Diaz-Ordaz, K., Williamson, E., Harrison, E. M., Hayward, A., Hemingway, H., Horby, P., Mehta, N., et al. (2020) · BMJ · doi:10.1136/bmj.m3731 · Cited by 539
Self-citationNeutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination
Wall, E. C., Wu, M., Harvey, R., Kelly, G., Warchal, S., Sawyer, C., Daniels, R., Hobson, P., Hatipoglu, E., Ngai, Y., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01290-3 · Cited by 491
Cumulative Incidence Estimation in the Presence of Competing Risks
Coviello, V., & Boggess, M. (2004) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0400400201 · Cited by 458
Hepatitis B Vaccine in Patients Receiving Hemodialysis: Immunogenicity and Efficacy
Stevens, C. E., Alter, H. J., Taylor, P. E., Zang, E. A., Harley, E. J., Szmuness, W., & the Dialysis Vaccine Trial Study Group (1984) · New England Journal of Medicine · doi:10.1056/nejm198408233110803 · Cited by 457
Hippisley-Cox, J., Young, D., Coupland, C., Channon, K. M., Tan, P. S., Harrison, D. A., Rowan, K., Aveyard, P., Pavord, I. D., & Watkinson, P. J. (2020) · Heart · doi:10.1136/heartjnl-2020-317393 · Cited by 351
Self-citationLeck, I. (1990) · BMJ · doi:10.1136/bmj.301.6752.608-c · Cited by 307
Explained Variation for Survival Models
Royston, P. (2006) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0600600105 · Cited by 303
Kennedy, N. A., Lin, S., Goodhand, J. R., Chanchlani, N., Hamilton, B., Bewshea, C., Nice, R., Chee, D., Cummings, J. F., Fraser, A., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-324789 · Cited by 272
Collins, G. S., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c2442 · Cited by 249
Collins, G. S., & Altman, D. G. (2012) · BMJ · doi:10.1136/bmj.e4181 · Cited by 244
Hippisley-Cox, J., & Coupland, C. (2017) · BMJ · doi:10.1136/bmj.j5019 · Cited by 216
Self-citationBaker, R. J., Mark, P. B., Patel, R. K., Stevens, K. K., & Palmer, N. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0553-2 · Cited by 211
Concordance for prognostic models with competing risks
Wolbers, M., Blanche, P., Koller, M. T., Witteman, J. C. M., & Gerds, T. A. (2014) · Biostatistics · doi:10.1093/biostatistics/kxt059 · Cited by 207
COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults
Clift, A. K., Coupland, C. A. C., Keogh, R. H., Hemingway, H., & Hippisley-Cox, J. (2021) · Annals of Internal Medicine · doi:10.7326/m20-4986 · Cited by 192
Self-citationCollins, G. S., & Altman, D. G. (2009) · BMJ · doi:10.1136/bmj.b2584 · Cited by 190
Katikireddi, S. V., Lal, S., Carrol, E. D., Niedzwiedz, C. L., Khunti, K., Dundas, R., Diderichsen, F., & Barr, B. (2021) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2020-216061 · Cited by 189
Self-citationKengne, A. P., Beulens, J. W., Peelen, L. M., Moons, K. G., van der Schouw, Y. T., Schulze, M. B., Spijkerman, A. M., Griffin, S. J., Grobbee, D. E., Palla, L., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70103-7 · Cited by 170
Patone, M., Thomas, K., Hatch, R. A., Tan, P. S., Coupland, C. A. C., Liao, W., Mouncey, P., Harrison, D. A., Rowan, K., Horby, P., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00318-2 · Cited by 141
Self-citationHippisley‐Cox, J., & Coupland, C. A. C. (2017) · BMJ · doi:10.1136/bmj.j4208 · Cited by 101
Self-citationAntibody responses after SARS-CoV-2 vaccination in patients with lymphoma
Lim, S. H., Campbell, N. A., Johnson, M., Joseph‐Pietras, D., Collins, G. P., O'Callaghan, A. M., Fox, C. P., Ahearne, M. J., Johnson, P., Goldblatt, D., et al. (2021) · The Lancet Haematology · doi:10.1016/s2352-3026(21)00199-x · Cited by 81
Self-citationNafilyan, V., Humberstone, B., Mehta, N., Diamond, I. D., Coupland, C. A. C., Lorenzi, L., Pawelek, P., Schofield, R., Morgan, J., Brown, P. M., et al. (2021) · The Lancet Digital Health · doi:10.1016/s2589-7500(21)00080-7 · Cited by 59
Self-citationRemschmidt, C., Wichmann, O., & Harder, T. (2014) · BMC Medicine · doi:10.1186/s12916-014-0244-9 · Cited by 58
Improvement in Cardiovascular Risk Prediction with Electronic Health Records
Pike, M. M., Decker, P., Larson, N., Sauver, J. S. S., Takahashi, P., Roger, V., Rocca, W., Miller, V., Olson, J., Pathak, J., et al. (2016) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-016-9687-z · Cited by 45
Hoes, J., Boef, A. G. C., Knol, M. J., de Melker, H. E., Mollema, L., van der Klis, F. R. M., Rots, N. Y., & van Baarle, D. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00209 · Cited by 25
Hippisley‐Cox, J., Clift, A. K., Coupland, C. A. C., Keogh, R. H., Diaz‐Ordaz, K., Williamson, E., Harrison, E. M., Hayward, A. C., Hemingway, H., Horby, P., et al. (2020) · medRxiv · doi:10.1101/2020.06.28.20141986 · Cited by 10
Self-citation
Cited by
Unmasking the COVID-19 pandemic prevention gains: excess mortality reversal in 2022
Walkowiak, M. P., Domaradzki, J., & Walkowiak, D. (2023) · Public Health · doi:10.1016/j.puhe.2023.08.004 · Cited by 28
Rountree, L., Lin, Y.-T., Liu, C., Salvatore, M., Admon, A., Nallamothu, B., Singh, K., Basu, A., Bu, F., & Mukherjee, B. (2025) · Online Journal of Public Health Informatics · doi:10.2196/66598 · Cited by 13
Metadata
- Authors
- Hippisley-Cox, J., Coupland, C. A., Mehta, N., Keogh, R. H., Diaz-Ordaz, K., Khunti, K., Lyons, R. A., Kee, F., Sheikh, A., Rahman, S., Valabhji, J., Harrison, E. M., Sellen, P., Haq, N., Semple, M. G., Johnson, P. W. M., Hayward, A., & Nguyen-Van-Tam, J. S.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2021-09-17
- Volume
- 374
- Pages
- n2244
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W3201642119
- Cited by
- 308
- References
- 39
- FWCI
- 20.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.